-
-
Overview
-
endo-BCN-PEG4-Val-Cit-PAB-MMAE is a precursor of antibody drug conjugate. It contains an endo-BCN-PEG4 spacer, a protease-sensitive Val-Cit dipeptide, a PABC linker and a MMAE payload. The MMAE is a synthetic antineoplastic agent. It can be attached to a monoclonal antibody (MAB) which directs it toward cancer cells.
Please contact us at for specific academic pricing.
-
- Properties
-
Overview